Client plans to outsource RA activities in EU countries for defined products
- High workload in local affiliates for established product portfolio in the EU
- New products registered in the countries lead to increasing workload
- Full RA responsibility for an established product portfolio to be outsourced for 16 EU countries
- Cover of all RA life cycle management tasks including labeling and interaction with local partners (incl. PV, medical)
- HA interactions done directly by PharmaLex